Thyroid disorder decisions — 2025

The Board denied a rating in excess of 40 percent for bilateral hearing loss and a rating in excess of 10 percent for tinnitus. The claims for service connection for various disabilities, including psychiatric conditions, lumbosacral spine disability, sleep apnea, pulmonary disease, esophageal issues, ulcers, intestinal problems, thyroid disorders, vertigo, headaches, TDIU, and special monthly compensation were remanded.

The Board granted an initial 10 percent rating for hypothyroidism status post thyroidectomy.

The Board denied service connection for a back condition, hypercholesterolemia, an acquired psychiatric condition (PTSD, fear of water, and fear of heights), asthma, left upper extremity carpal tunnel syndrome, right upper extremity carpal tunnel syndrome, and hypothyroidism.

The Board dismissed all appeals as the Veteran did not submit a valid Notice of Disagreement (NOD) for each appeal.

The Board remands the claims for service connection for type 2 diabetes mellitus, hypertension, and hypothyroidism to verify exposure to herbicide agents in the Korean DMZ and obtain additional medical opinions.

The Board denied an initial compensable rating for thyroid cancer, status post thyroidectomy with residual hypothyroidism and hypoparathyroidism, but granted an effective date of November 19, 2021, for the award of service connection.

The Board denied service connection for hearing loss and tinnitus, as well as remanded claims for hepatitis, diabetes mellitus, prostate condition, thyroid condition, and erectile dysfunction.

The Board denied the Veteran's August 2023 Application for Disability Compensation and Related Compensation Benefits (VA Form 21-526EZ) as it was the incorrect form to file when seeking to reopen previously denied claimed disorders.

The Board denied service connection for various conditions, including Graves' disease, hysterectomy, hypothyroidism, loss of smell, bilateral hearing loss, anxiety and depression, and vision condition.

The Board granted service connection for hypothyroidism based on the presumption that it was chronic during active service.

The Board remands the claims for service connection for thyroid and cervical spine disabilities to correct duty to assist errors that occurred prior to the August 2021 rating decision on appeal.

The Board remands the claim for a VA endocrinological examination to address the medical treatises submitted by the Veteran in July 2021 and ensure compliance with previous remand instructions.

The Board denied an increased rating for coronary artery disease and a compensable rating for hypertension, while remanding the claim for hypothyroidism.

The Board denied service connection for thyroid nodules, soft tissue sarcoma, and lymphoma, all claimed as due to Agent Orange exposure during the Veteran's service in Vietnam.

The appeal for service connection for hypothyroidism was dismissed as the Veteran did not withdraw his request for higher-level review, and the benefit sought on appeal had already been granted. The appeal for service connection for bilateral hip pain (osteoarthritis) was remanded for further development.

The Veteran withdrew his appeals for service connection for thyroid cancer, nerves (claimed as anxiety/mood swings), and sleep apnea.

The Veteran's service-connected ischemic heart disease was granted a 30 percent increased disability evaluation, effective May 8, 2022. Service connection for hypothyroidism and a compensable rating for hypertension were denied.

The Board remands the case for a new and adequate VA examination to correct a duty to assist error on the part of the originating agency in satisfying its duties under 38 U.S.C. § 5103A.

All claims for service connection and effective date were dismissed due to lack of new evidence or legal basis.

The Board granted the restoration of service connection for hypertension, as the grant was not clear and unmistakable error. The claims for diabetes, hypothyroidism, and bilateral peripheral neuropathy were remanded due to duty to assist errors.